Cleared Traditional

K063177 - RAPID STRAND RX

K063177 is an FDA 510(k) clearance for RAPID STRAND RX, manufactured by Oncura, Inc.. The device is a Class 2 Radiology device with product code KXK cleared through the Traditional 510(k) pathway after a 42-day FDA review.

K063177 · Oncura, Inc. · Radiology device
Download Printable Device Report (PDF) Official FDA 510(k) Summary (PDF)
Optimized for regulatory review, auditing and printing
Nov 2006
Decision
42d
Days
Class 2
Risk

K063177 is an FDA 510(k) clearance for the RAPID STRAND RX. Classified as Source, Brachytherapy, Radionuclide (product code KXK), Class II - Special Controls.

Submitted by Oncura, Inc. (North Brunswick, US). The FDA issued a Cleared decision on November 30, 2006 after a review of 42 days - a notably fast clearance cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.5730 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

FDA 510(k) Submission Details - K063177

510(k) Number K063177 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 19, 2006
Decision Date November 30, 2006
Days to Decision 42 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
65d faster than avg
Panel avg: 107d · This submission: 42d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

KXK Device Classification - Class 2, Special Controls

Product Code KXK Source, Brachytherapy, Radionuclide
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.5730
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - KXK Source, Brachytherapy, Radionuclide

All 150
Devices cleared under the same product code (KXK) and FDA review panel - the closest regulatory comparables to K063177.
AOS MARKER SEEDS
K062825 · Alpha-Omega Services, Inc. · May 2007
IMPLANT SCIENCES CORP. MODEL HDR 4454
K070468 · Implant Sciences Corp. · Mar 2007
BRACHYSCIENCES STRANDPORT
K062214 · Worldwide Medical Technologies, LLC · Mar 2007
CESIUM-131 STRAND, STRAND PRELOAD, PRELOAD, S-CARTRIDGE
K062384 · Isoray, Inc. · Nov 2006
BEST STRAND AND BEST SPACER
K061638 · Best Medical International, Inc. · Aug 2006
SURTRAK IMPLANTATION KIT
K060679 · North American Scientific, Inc. · Apr 2006
K063177 · RAPID STRAND RX
Download PDF FDA Summary Oncura, Inc.